Skip to main content
FHTX logo
FHTX
(NASDAQ)
Foghorn Therapeutics Inc.
$4.92-- (--)
Loading... - Market loading

Foghorn Therapeutics (FHTX) Stock Price & Financial Analysis

Foghorn Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.70 - $5.00
52-Week High$7.61
52-Week Low$3.27
Open$4.81
Volume264.36K
Average Volume (3M)332.32K
Market Cap342.14M
Shares Outstanding69.54M
Price to Sales (P/S)12.12
Price to Book (P/B)-4.48
EV/EBITDA-3.93
Revenue (TTM)28.22M
Net Income (TTM)-75.32M
Free Cash Flow (TTM)-87.42M
EPS (TTM)$-1.17
Profit Margin-266.88%
Operating Margin-286.16%
50-Day MA$5.63
200-Day MA$5.11
52-Week Change-14.73%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Foghorn Therapeutics

What is the current stock price for FHTX?

As of the latest trading session, FHTX stock trades at $4.92. The 52-week range is $3.27–$7.61, with a day range of $4.70–$5.00.

What is the P/E ratio for FHTX?

The P/E ratio (Price-to-Earnings) for FHTX is shown in the Key Statistics section. This valuation metric helps compare Foghorn Therapeutics Inc. to industry peers.

Does FHTX pay dividends?

Foghorn Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for FHTX?

Analyst ratings and recommendations for FHTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of FHTX?

Foghorn Therapeutics's market capitalization is $342.1M, classifying it as a small-cap company. Foghorn Therapeutics operates in the Healthcare sector within the Biotechnology industry.